Punch & Associates Investment Management, Inc. Eli Lilly & CO Transaction History

Punch & Associates Investment Management, Inc.

$1.68 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $2.87 Million - $3.38 Million	5,463 New	5,463 $3.18 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.39 Million - $1.87 Million	-3,977 Reduced 41.91%	5,513 $2.59 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $587,401 - $689,874	-1,891 Reduced 16.62%	9,490 $3.26 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $128,620 - $149,868	400 Added 3.64%	11,381 $4.16 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $19,561 - $24,276	-87 Reduced 0.79%	10,981 $3.03 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $125,868 - $154,899	568 Added 5.41%	11,068 $2.56 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $70,053 - $90,613	-388 Reduced 3.56%	10,500 $2.41 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.3 Million - $1.6 Million	10,888 New	10,888 $1.51 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$75.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$57.4 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$51.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.4 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Account